{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:30:15Z","timestamp":1763037015360},"reference-count":31,"publisher":"Codon Publications","issue":"2","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Allergologia et Immunopathologia"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.aller.2016.06.007","type":"journal-article","created":{"date-parts":[[2016,10,29]],"date-time":"2016-10-29T00:15:21Z","timestamp":1477700121000},"page":"134-144","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Management of chronic spontaneous urticaria in routine clinical practice: A Delphi-method questionnaire among specialists to test agreement with current European guidelines statements"],"prefix":"10.15586","volume":"45","author":[{"given":"A.","family":"Gim\u00e9nez-Arnau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Bartra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"J\u00e1uregui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Labrador-Horrillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Ortiz de","family":"Frutos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.F.","family":"Silvestre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Sastre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Velasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Valero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6228","reference":[{"key":"10.1016\/j.aller.2016.06.007_bib0160","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1046\/j.1365-2133.1997.d01-1168.x","article-title":"The impact of chronic urticaria on the quality of life","volume":"136","author":"O\u2019Donnell","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.aller.2016.06.007_bib0165","first-page":"214","article-title":"Epidemiology of urticaria in Spain","volume":"14","author":"Gaig","year":"2004","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.aller.2016.06.007_bib0170","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/cea.12465","article-title":"Management of urticaria: not too complicated, not too simple","volume":"45","author":"Ferrer","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.aller.2016.06.007_bib0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2011.04.038","article-title":"Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase","volume":"128","author":"Maurer","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.aller.2016.06.007_bib0180","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJMoa1215372","article-title":"Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria","volume":"368","author":"Maurer","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.aller.2016.06.007_bib0185","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jaci.2013.05.013","article-title":"Omalizumab in patients with symptomatic chronic idiopathic\/spontaneous urticaria despite standard combination therapy","volume":"132","author":"Kaplan","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.aller.2016.06.007_bib0190","unstructured":"Fitch K, Bernstein SJ, Aguilar MD, Burnand B, LaCalle JR, Lazaro P, et al. The RAND\/UCLA Appropriateness Method User's Manual | RAND. [Accessed on 16.01.13]. Available from: http:\/\/www.rand.org\/pubs\/monograph_reports\/MR1269.html."},{"key":"10.1016\/j.aller.2016.06.007_bib0195","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000342424","article-title":"Clinical management of patients with a history of urticaria\/angioedema induced by multiple NSAIDs: an expert panel review","volume":"160","author":"Asero","year":"2013","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.aller.2016.06.007_bib0200","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000088724","article-title":"Food-additive-induced urticaria: a survey of 838 patients with recurrent chronic idiopathic urticaria","volume":"138","author":"Di Lorenzo","year":"2005","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.aller.2016.06.007_bib0205","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jaip.2013.10.002","article-title":"Prevalence of sensitivity to food and drug additives in patients with chronic idiopathic urticaria","volume":"2","author":"Rajan","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.aller.2016.06.007_bib0210","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.jaci.2014.02.036","article-title":"The diagnosis and management of acute and chronic urticaria: 2014 update","volume":"133","author":"Bernstein","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.aller.2016.06.007_bib0215","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.jaci.2013.04.037","article-title":"D-dimer: a biomarker for antihistamine-resistant chronic urticaria","volume":"132","author":"Asero","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.aller.2016.06.007_bib0220","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.jaci.2014.11.016","article-title":"Plasma D-dimer levels and clinical response to cyclosporin in severe chronic spontaneous urticaria","volume":"135","author":"Asero","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.aller.2016.06.007_bib0225","first-page":"426","article-title":"Adaptation and validation of the Spanish version of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL)","volume":"18","author":"Valero","year":"2008","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.aller.2016.06.007_bib0230","first-page":"CD006137","article-title":"H1-antihistamines for chronic spontaneous urticaria","volume":"11","author":"Sharma","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 3","key":"10.1016\/j.aller.2016.06.007_bib0235","first-page":"34","article-title":"Effect of antihistamine up-dosing in chronic urticaria","volume":"21","author":"Ferrer","year":"2011","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.aller.2016.06.007_bib0240","doi-asserted-by":"crossref","first-page":"168","DOI":"10.2340\/00015555-1434","article-title":"Can on-demand non-sedating antihistamines improve urticaria symptoms? A double-blind, randomized, single-dose study","volume":"93","author":"Weller","year":"2013","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.aller.2016.06.007_bib0245","article-title":"Systematic review of treatments for chronic spontaneous urticaria with inadequate response to licensed first-line treatments","author":"Mitchell","year":"2014","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.aller.2016.06.007_bib0250","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1710-1492-10-24","article-title":"Leukotriene receptor antagonists for chronic urticaria: a systematic review","volume":"10","author":"De Silva","year":"2014","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.aller.2016.06.007_bib0315","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s40265-013-0085-4","article-title":"Omalizumab: a review of its use in patients with severe persistent allergic asthma","volume":"73","author":"McKeage","year":"2013","journal-title":"Drugs"},{"key":"10.1016\/j.aller.2016.06.007_bib0260","unstructured":"European Medicine Agency Assesment report. Xolair (omalizumab) [Accessed on 29.12.14]. Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Assessment_Report_-_Variation\/human\/000606\/WC500164453.pdf."},{"key":"10.1016\/j.aller.2016.06.007_bib0265","unstructured":"Food and Drug Administration. Clinical Review. Xolair (omalizumab) [Accessed on 29.12.14]. Available from: http:\/\/www.fda.gov\/downloads\/drugs\/developmentapprovalprocess\/developmentresources\/ucm393854.pdf."},{"key":"10.1016\/j.aller.2016.06.007_bib0270","unstructured":"European Medicine Agency Summary of product characteristics. Xolair (omalizumab) [Accessed on 29.12.14]. Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000606\/WC500057298.pdf."},{"key":"10.1016\/j.aller.2016.06.007_bib0275","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/jamadermatol.2013.8705","article-title":"Retreatment with omalizumab results in rapid remission in chronic spontaneous and inducible urticaria","volume":"150","author":"Metz","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.aller.2016.06.007_bib0280","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1517\/14712598.2013.822484","article-title":"Efficacy of omalizumab in chronic spontaneous urticaria refractory to conventional therapy: analysis of 110 patients in real-life practice","volume":"13","author":"Labrador-Horrillo","year":"2013","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.aller.2016.06.007_bib0285","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1365-2133.2007.08283.x","article-title":"British Association of Dermatologists Therapy Guidelines and Audit Subcommittee. Guidelines for evaluation and management of urticaria in adults and children","volume":"157","author":"Grattan","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.aller.2016.06.007_bib0290","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1525-1470.2011.01518.x","article-title":"Evidence-based evaluation and management of chronic urticaria in children","volume":"28","author":"Zitelli","year":"2011","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.aller.2016.06.007_bib0295","doi-asserted-by":"crossref","unstructured":"Potter P, Mitha E, Barkai L, Domenech A, Santamaria E, Giralt J, et al. Clinical and Translational Allergy | Full text | O10 \u2013 Rupatadine is effective and safe in the treatment of Chronic Spontaneous Urticaria (CSU) in pediatric patients (2\u201311 years old) [Accessed on 9.04.15]. Available from: http:\/\/www.ctajournal.com\/content\/4\/S1\/O10.","DOI":"10.1186\/2045-7022-4-S1-O10"},{"key":"10.1016\/j.aller.2016.06.007_bib0300","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.iac.2013.09.006","article-title":"Urticaria and angioedema in pregnancy and lactation","volume":"34","author":"Lawlor","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.aller.2016.06.007_bib0305","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios. Ficha t\u00e9cnica Atarax. [Accessed on 29.12.14]. Available from: http:\/\/www.aemps.gob.es\/cima\/pdfs\/es\/ft\/26269\/FT_26269.pdf."},{"key":"10.1016\/j.aller.2016.06.007_bib0310","unstructured":"Biobadaderm Registro Espa\u00f1ol de Tratamientos Sistemicos en Psoriasis [Accessed on 29.12.14]. Available from: https:\/\/biobadaser.ser.es\/biobadaderm\/."}],"container-title":["Allergologia et Immunopathologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301054616301070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301054616301070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T22:50:52Z","timestamp":1609455052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301054616301070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0301054616301070"],"URL":"https:\/\/doi.org\/10.1016\/j.aller.2016.06.007","relation":{},"ISSN":["0301-0546"],"issn-type":[{"value":"0301-0546","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of chronic spontaneous urticaria in routine clinical practice: A Delphi-method questionnaire among specialists to test agreement with current European guidelines statements","name":"articletitle","label":"Article Title"},{"value":"Allergologia et Immunopathologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aller.2016.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 SEICAP. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}